Papers/PMID:22469850
Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.
Osteoarthritis and cartilage2012The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
chondroitin sulfate — decreases WOMAC stiffness subscale
Evidence strength: very limited.Finding“Chondroitin sulfate used alone was also found to be effective in reducing WOMAC total score and stiffness score (P=0.038 and P=0.023, respectively).”
Quoted verbatim from Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.. - Study
- RCT
- Duration
- 6 months
- Population
- adults with Kashin-Beck disease (KBD), chondroitin sulfate monotherapy arm, cluster-randomised trial
Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.2012PMID:2246985010.1016/j.joca.2012.03.013Permalink